Camlin Fine Sciences Limited (BOM:532834)

Market Cap	32.83B +56.2%
Revenue (ttm)	17.52B +9.0%
Net Income	-292.05M
EPS	-1.61
Shares Out	192.09M
PE Ratio	166.70
Forward PE	39.98
Dividend	n/a
Ex-Dividend Date	n/a

Volume	15,192
Average Volume	40,246
Open	172.60
Previous Close	172.55
Day's Range	168.90 - 172.70
52-Week Range	128.10 - 334.70
Beta	0.22
RSI	61.50
Earnings Date	Feb 2, 2026

About Camlin Fine Sciences

Camlin Fine Sciences Limited, together with its subsidiaries, research, develops, manufactures, and markets specialty chemicals, ingredients, and additive blend products in India and internationally. The company offers shelf-life solutions, which include basic ingredients, such as tert-butylhydroquinone (TBHQ), Butylated Hydroxyanisole (BHA), Butylated Hydroxytoluene (BHT), and Ascorbyl Palmitate (ASP); aroma ingredients, including vanillin and ethyl vanillin, natural vanillin, and some of its combinations; performance chemicals that include Hy...

• Industry: Chemicals and Allied Products
• Founded: 1931
• Employees: 661
• Stock Exchange: Bombay Stock Exchange
• Ticker Symbol: 532834

Financial Performance

In fiscal year 2025, Camlin Fine Sciences's revenue was 16.67 billion, an increase of 14.62% compared to the previous year's 14.54 billion. Losses were -1.39 billion, 49.9% more than in 2024.